ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
Dow Jones
38.852,27
0,46%
Euro vs US Dollar
1,07685
0,10%
Bitcoin
63.127,34
-0,06%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Rigel Pharmaceuticals Inc (RIGL)

  7. Rigel Pharmaceuticals Inc (RIGL) News

RIGL

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RIGL
DatumZeitQuelleÜberschriftSymbolFirma
30/04/202414h05PR Newswire (US)Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
10/04/202422h30PR Newswire (US)Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
04/04/202414h05PR Newswire (US)Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & LymphomaNASDAQ:RIGLRigel Pharmaceuticals Inc
12/03/202413h05PR Newswire (US)Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical OfficerNASDAQ:RIGLRigel Pharmaceuticals Inc
05/03/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
05/03/202422h06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RIGLRigel Pharmaceuticals Inc
05/03/202422h01PR Newswire (US)Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
02/03/202401h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
02/03/202401h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
02/03/202401h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
02/03/202401h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
27/02/202414h05PR Newswire (US)Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
22/02/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
22/02/202413h50PR Newswire (US)Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®NASDAQ:RIGLRigel Pharmaceuticals Inc
14/02/202420h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
07/02/202402h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
07/02/202402h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
07/02/202402h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
02/02/202415h56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
26/01/202403h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
26/01/202403h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
26/01/202403h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
26/01/202403h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
25/01/202419h48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
08/01/202414h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
08/01/202414h05PR Newswire (US)Rigel Pharmaceuticals Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
05/01/202422h30PR Newswire (US)Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
04/01/202414h05PR Newswire (US)Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in GliomaNASDAQ:RIGLRigel Pharmaceuticals Inc
03/01/202414h05PR Newswire (US)Rigel to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
08/12/202314h05PR Newswire (US)Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA® (Olutasidenib) in AML and Other CancersNASDAQ:RIGLRigel Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RIGL

Kürzlich von Ihnen besucht

CCOM
SILVER
SILVER
COIN
SOLUSD
Solana
NASDAQ
GOOGL
Alphabet
FX
EURUSD
Euro vs US Dollar
NASDAQ
AAPL
Apple
TG
TUI1
Tui
NASDAQ
TSLA
Tesla
USOTC
BASFY
BASF (QX)
NYSE
XOM
Exxon Mobil
NASDAQ
MSFT
Microsoft
AMEX
XLE
Energy Select Sector SPDR
TG
NOV
Novo Nordisk
CCOM
US100
US Tech 100
DBI
DAX
DAX
TG
CBK
Commerzbank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten